Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50% ; volume:72 ; number:6 ; day:24 ; month:1 ; year:2023 ; pages:1881-1890 ; date:6.2023
Cancer immunology immunotherapy ; 72, Heft 6 (24.1.2023), 1881-1890, 6.2023
- Creator
-
Pons-Tostivint, E.
Hulo, P.
Guardiolle, V.
Bodot, L.
Rabeau, A.
Porte, M.
Hiret, S.
Demontrond, P.
Curcio, H.
Boudoussier, A.
Veillon, R.
Mayenga, M.
Dumenil, C.
Chatellier, T.
Gourraud, P. A.
Mazieres, J.
Bennouna, J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03359-2
- URN
-
urn:nbn:de:101:1-2023090911380300075122
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
18.10.2142, 12:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pons-Tostivint, E.
- Hulo, P.
- Guardiolle, V.
- Bodot, L.
- Rabeau, A.
- Porte, M.
- Hiret, S.
- Demontrond, P.
- Curcio, H.
- Boudoussier, A.
- Veillon, R.
- Mayenga, M.
- Dumenil, C.
- Chatellier, T.
- Gourraud, P. A.
- Mazieres, J.
- Bennouna, J.
- SpringerLink (Online service)
Other Objects (12)
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA